Patent · US Active

3′ end caps for RNAi agents for use in RNA interference

US11008570B2 · kind B2 · utility

0Cited by
64References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 16, 2019
Grant dateMay 18, 2021
Priority date
Expiry dateJan 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The disclosure relates to novel compounds and compositions comprising a RNAi agent comprising a novel compound as a 3′ end cap. The disclosure also relates to processes for making such compositions, and methods and uses of such compositions, e.g., to mediate RNA interference.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.